Search company, investor...
Integrated BioTherapeutics company logo

Integrated BioTherapeutics

integratedbiotherapeutics.com

Founded Year

2005

Stage

Unattributed - II | Alive

Total Raised

$8.78M

Last Raised

$50K | 1 yr ago

About Integrated BioTherapeutics

Integrated BioTherapeutics focuses on the discovery of vaccines and therapies for emerging infectious diseases with a pipeline that includes product candidates for bacterial and viral infections, including pan-filovirus immunotherapeutics and vaccines, vaccines for Staphylococcal infections, and a variety of other product candidates for emerging viruses.

Headquarters Location

4 Research Court Suite 300

Rockville, Maryland, 20850,

United States

877-411-2041

Missing: Integrated BioTherapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Integrated BioTherapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Integrated BioTherapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Integrated BioTherapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

838 items

Integrated BioTherapeutics Patents

Integrated BioTherapeutics has filed 17 patents.

The 3 most popular patent topics include:

  • Immunology
  • Bacterial toxins
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/13/2018

8/23/2022

Immune system, Bacterial diseases, Bacterial toxins, Clusters of differentiation, Immunology

Grant

Application Date

6/13/2018

Grant Date

8/23/2022

Title

Related Topics

Immune system, Bacterial diseases, Bacterial toxins, Clusters of differentiation, Immunology

Status

Grant

Latest Integrated BioTherapeutics News

Hepatitis C Virus Envelope Protein E2 Market to Witness Huge Growth by 2029 |Aviragen Therapeutics Inc, Integrated BioTherapeutics Inc,

May 16, 2022

Marseille, France) – The Global Hepatitis C Virus Envelope Protein E2 Market Intelligence Report is a valuable source of insightful data for business strategists. Provides an industry overview with growth analysis and historical & future cost, revenue, demand and supply data (as applicable). Research analysts provide a detailed description of the value chain and analysis […] The post Hepatitis C Virus Envelope Protein E2 Market to Witness Huge Growth by 2029 |Aviragen Therapeutics Inc, Integrated BioTherapeutics Inc, appeared first on Archyworldys.

Integrated BioTherapeutics Frequently Asked Questions (FAQ)

  • When was Integrated BioTherapeutics founded?

    Integrated BioTherapeutics was founded in 2005.

  • Where is Integrated BioTherapeutics's headquarters?

    Integrated BioTherapeutics's headquarters is located at 4 Research Court, Rockville.

  • What is Integrated BioTherapeutics's latest funding round?

    Integrated BioTherapeutics's latest funding round is Unattributed - II.

  • How much did Integrated BioTherapeutics raise?

    Integrated BioTherapeutics raised a total of $8.78M.

  • Who are the investors of Integrated BioTherapeutics?

    Investors of Integrated BioTherapeutics include National Cancer Institute and National Institute of Allergy and Infectious Diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.